Aquatic Capital Management LLC

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1803916 CHICAGO, IL

Position in CLDX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,627,677

+$1,464,954 QoQ

Shares Held

43,743

+752.7% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#108

of 252 holders

Holding Since

Sep 2022

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Aquatic Capital Management LLC holds $144,356,048 across 88 Biotechnology names. CLDX ranks #25 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	32,577	$20,313,062
2	CYTK	Cytokinetics Inc	125,090	$10,656,417
3	TVTX	Travere Therapeutics, Inc.	157,710	$8,959,505
4	ARGX	Argenx SE	7,697	$7,141,045
5	PTCT	Ptc Therapeutics, Inc.	83,470	$6,808,647
6	TGTX	Tg Therapeutics, Inc.	99,530	$5,468,178
7	ALNY	Alnylam Pharmaceuticals, Inc.	15,480	$4,659,944
8	MIRM	Mirum Pharmaceuticals, Inc.	36,670	$4,292,956

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,627,677	43,743	+752.7%	Shares	Sole	2026-08-14
2026-03-31	$162,723	5,130	-78.6%	Shares	Sole	2026-05-15
2025-06-30	$487,687	23,965	+118.3%	Shares	Sole	2025-08-14
2025-03-31	$199,214	10,976	+129.6%	Shares	Sole	2025-05-15
2024-12-31	$120,790	4,780	+16.6%	Shares	Sole	2025-02-14
2024-03-31	$172,077	4,100	+20.6%	Shares	Sole	2024-05-15
2023-12-31	$134,844	3,400	-77.2%	Shares	Sole	2024-02-14
2023-03-31	$536,102	14,900	-3.9%	Shares	Sole	2023-05-15
2022-09-30	$435,705	15,500	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.